New treatment option shows promise for severe hypertrophic cardiomyopathy in children
Graphical summary. Credit score: JACC: Primary to Translational Science (2024). DOI: 10.1016/j.jacbts.2024.10.002 Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces ...